Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
60,055,283
-
Shares change
-
+2,752,091
-
Total reported value, excl. options
-
$187,971,528
-
Value change
-
-$2,108,993
-
Put/Call ratio
-
79%
-
Number of buys
-
80
-
Number of sells
-
-54
-
Price
-
$3.13
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q1 2023
159 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q1 2023.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60,055,283 shares
.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (6,887,591 shares), Avidity Partners Management LP (6,519,400 shares), ORBIMED ADVISORS LLC (5,463,000 shares), BlackRock Inc. (4,457,990 shares), STATE STREET CORP (3,239,433 shares), Prosight Management, LP (3,200,000 shares), VANGUARD GROUP INC (3,012,116 shares), MILLENNIUM MANAGEMENT LLC (2,537,103 shares), SPHERA FUNDS MANAGEMENT LTD. (1,888,228 shares), and Hood River Capital Management LLC (1,430,654 shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.